Oral administration of Medicated ayurveda preparation in management of Asthma.

A single arm clinical study to evaluate the efficacy of Pippali Arka in the management of Tamaka Shwasa(Bronchial Asthama) - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085574

Enrollment

Registered

2025-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J99- Respiratory disorders in diseasesclassified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient fulfilling the diagnostic criteria. 2.Patient between age group of 18-60 years irrespective of sex and Religion. 3.Patient who will be given written consent.

Exclusion criteria

Exclusion criteria: 1.Bronchial asthma having severe attack who requires oxygen and nebulization support 2.Patient with severe persistent bronchial asthma as per GINA criteria. 3.Patients with other systemic disorders which may interfere with the course of the study such as Uncontrolled Hypertension, DM. 4.Other complicated respiratory disorders like COPD, TB, Pneumonia, etc. 5.Patients on corticosteroids therapy, Smokers 6.Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
To study the efficacy of Pippali Arka in reducing signs and symptoms of Tamakaswasa. Timepoint: Initially on the 0th day before treatment On the 8th day,15th day,29th day	—

Secondary

Measure	Time frame
To Assess the change in peak expiratory flow rate. Timepoint: 28 days	—

Countries

India

Contacts

Public ContactDr B Shivani Shetty

Alvas Ayurveda Medical College

mdalvasayu@gmail.com8921385332

Outcome results